Patterns of 21-gene Assay Testing and Chemotherapy Use in Black and White Breast Cancer Patients

PURPOSE: In women with early stage, estrogen-receptor (HR)-positive breast cancer, the 21-gene recurrence score (RS) assay quantifies recurrence risk and predicts chemotherapy responsiveness. Recent data suggest that not all women with early-stage, HR+ disease receive this testing. We examined socio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Breast Cancer
Hauptverfasser: Sheppard, Vanessa B., O’Neill, Suzanne C., Dilawari, Asma, Horton, Sara, Hirpa, Fikru A., Isaacs, Claudine
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266534/
https://ncbi.nlm.nih.gov/pubmed/25555816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2014.11.011
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge